Case Study: Independent Pharmacy Group Achieves DMEPOS Accreditation Across Six Locations After Prior Compliance Failures
Situation Overview
A regional independent pharmacy group with six locations had been billing Medicare Part B for diabetic supplies, nebulizers, and ostomy products for over a decade under a legacy accreditation held by the original owner. Following a change in ownership, the accreditation lapsed during the transition — a gap the new owners did not discover until two locations received Medicare billing suspension notices from the National Supplier Clearinghouse. The group's Medicare DMEPOS revenue across all six locations represented a significant portion of total pharmacy revenue. With billing suspended at two locations and the other four at risk, the group engaged IHS for emergency accreditation recovery.
Challenges
- Emergency timeline: Medicare billing was suspended at two locations. Every day of suspension represented direct revenue loss. The group needed accreditation as quickly as possible without cutting corners that would result in deficiencies.
- Documentation absent at all locations: The prior accreditation had been held under the old owner. No policies, procedures, or compliance documentation had transferred with the acquisition. All six locations were starting from zero on documentation.
- Six locations with varying operations: The six pharmacies had different product mixes, physical layouts, and staffing structures. Documentation needed to be tailored to each location while maintaining consistency across the group's compliance framework.
- Medicare supplier standards violations: The NSC investigation triggered by the billing suspension identified two locations with deficiencies in the Medicare supplier standards — specifically, inadequate liability insurance coverage and outdated pharmacist-in-charge designations. These violations needed to be corrected before accreditation could be granted.
- 2026 annual renewal transition: The engagement spanned the January 1, 2026 effective date of CMS's shift to annual accreditation terms. The group needed to plan for annual renewal from the outset rather than building toward a 3-year cycle.
IHS Approach
Given the emergency nature of the engagement, IHS deployed a parallel-track approach: immediate corrective action on the NSC compliance violations while simultaneously building the documentation infrastructure needed for NABP accreditation.
Track 1: NSC Compliance Violation Remediation
IHS worked directly with the group's operations director to correct the two identified Medicare supplier standards violations. New liability insurance certificates at the required coverage levels were obtained. Pharmacist-in-charge designations were updated at all six locations with formal documentation of each PIC's licensure and responsibilities. Written certification of compliance with all 30 Medicare supplier standards was executed for each location. NSC was notified of the corrections, and billing suspensions were lifted at both affected locations within 19 days of engagement start.
Track 2: Documentation Infrastructure Build
IHS developed a core policy and procedure framework applicable across all six locations, covering DMEPOS product receipt, patient intake and needs assessment, delivery and setup, patient training, equipment maintenance (for rental items), complaint handling, ABN procedures, medical necessity documentation, billing compliance, and quality assurance. Location-specific addenda were developed for each pharmacy reflecting differences in product mix, staffing, and physical layout.
Track 3: Personnel Training Program
IHS developed a staff training curriculum covering Medicare DMEPOS requirements, CMS Quality Standards, ABN usage, medical necessity documentation, and complaint handling. Training was delivered to pharmacy managers and designated DMEPOS staff at all six locations over a two-week period. Training records were documented for inclusion in the accreditation application.
Track 4: Annual Compliance Program Design
Given the shift to annual accreditation terms effective January 1, 2026, IHS designed a compliance calendar and annual renewal checklist for the group. This included automated reminders for insurance renewal, license expiration, PIC designation reviews, and documentation updates. The goal was to ensure the group would never again face an accreditation lapse due to administrative oversight.
NABP Application and Accreditation
IHS prepared separate NABP accreditation applications for each of the six pharmacy locations. Applications were submitted in two batches — two locations first (the suspended locations, on emergency track), then four additional locations two weeks later. NABP granted accreditation to both emergency-track locations in week 11 of the engagement and to all four remaining locations by week 14.
Outcomes
- Medicare billing restored at two suspended locations within 19 days of engagement start
- NABP DMEPOS Pharmacy Accreditation granted at all six locations within 14 weeks
- Complete documentation infrastructure built from scratch across all six locations
- Staff training completed at all locations with documented training records
- Annual compliance calendar implemented to prevent future accreditation lapses
- No accreditation deficiency findings across any of the six applications
Key Lessons
Ownership transitions are high-risk periods for accreditation continuity. This group lost its accreditation during an acquisition because no one in the transaction specifically tracked accreditation status as a compliance asset. Buyers in pharmacy acquisitions should treat accreditation status as a material due diligence item and plan for continuity or reaccreditation as part of the deal structure.
Annual renewal requires infrastructure, not just intention. The shift to 1-year DMEPOS Pharmacy Accreditation terms as of January 2026 means there is no longer a three-year buffer. Groups with multiple locations must build systematic compliance calendars that treat accreditation renewal as an operational process, not an ad hoc project.
Medicare supplier standards violations can be corrected quickly if approached correctly. The billing suspensions in this case were resolved faster than the group expected because the underlying violations were addressable — documentation and insurance gaps, not billing fraud or serious quality failures. Moving quickly and communicating directly with NSC was the key.
Facing a DMEPOS Accreditation Challenge?
Whether you are starting from scratch, recovering from a lapse, or preparing for the annual renewal cycle under the 2026 CMS rule change, IHS provides the structured expertise to get your pharmacy accredited and keep it accredited. Schedule a Free Discovery Session with Thomas G. Goddard, JD, PhD — former Chief Operating Officer and General Counsel of URAC.